Pathophysiological and clinical point of view on Kawasaki disease and MIS-C

Lenka Vaňková1, Jiří Bufka2, Věra Křížková1

  • 1Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Czech Republic.

PubMed

Insights

Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) share inflammatory pathways but are distinct diseases. Differences in epidemiology, etiology, and specific pathophysiological processes differentiate them, requiring further research.

Area of Science:

  • Pediatric immunology
  • Infectious diseases
  • Rheumatology

Background:

  • Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) are pediatric inflammatory conditions with overlapping clinical features.
  • Both conditions are temporally associated with infections and involve immune system alterations and systemic inflammation.

Purpose of the Study:

  • To compare the pathophysiological states of Kawasaki disease and MIS-C.
  • To elucidate the similarities and differences in their epidemiological, etiological, and pathophysiological aspects.
  • To identify areas for future research to better understand disease development.

Main Methods:

  • Comparative analysis of existing literature on Kawasaki disease and MIS-C.
  • Examination of shared pathophysiological mechanisms, including interleukin-1, inflammasome activation, pyroptosis, and NETosis.
  • Review of epidemiological and etiological data to differentiate the two conditions.

Main Results:

  • Both Kawasaki disease and MIS-C exhibit overlapping clinical presentations and share common inflammatory pathways.
  • Significant differences exist in epidemiological patterns, etiological factors, and the frequency/development of specific clinical signs.
  • These distinctions confirm Kawasaki disease and MIS-C as separate entities despite shared inflammatory processes.

Conclusions:

  • Kawasaki disease and MIS-C, while sharing inflammatory pathways, are distinct diseases with unique epidemiological and etiological profiles.
  • Further research into understudied areas is crucial for a comprehensive understanding of their development.
  • Distinguishing between these conditions is vital for appropriate diagnosis and management in pediatric populations.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17